Integrated Annual Report

Overview

The report presents Orion Pharma Limited's 2022-23 integrated performance across pharmaceutical and power operations, with consolidated net sales revenue of BDT 13,926.60 million. It reports 2,716 employees and states that women account for 43% of board members. Environmental initiatives highlighted include installed solar PV panels at the new plant, energy-efficient lighting and natural-daylight use. The report also describes operational measures to reduce environmental impacts through resource efficiency and pollution control.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2022-2023
Period: 1 July 2022 – 30 June 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services